Zu "151823-14-2" wurden 2 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Sapacitabine
Artikelnummer: Cay27321-10
Sapacitabine is a prodrug form of the nucleoside derivative CNDAC (Cay-40672). In vivo, sapacitabine (5 and 15 mg/kg) reduces tumor volume in an MV4-11 mouse xenograft model when administered alone or in combination with the histone deacetylase (HDAC) inhibitor SAHA (vorinostat, Cay-10009929).Formal Name:...
| Schlagworte: | CS 682, CYC-682, N-[1-(2-cyano-2-deoxy-b-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]-hexadecanamide |
| Anwendung: | Nucleoside derivative CNDAC prodrug form, antineoplastic, antimetabolite |
| CAS | 151823-14-2 |
| MW: | 490.6 D |
ab 107,00 €
Sapacitabine
Artikelnummer: TGM-TQ0245-2mg
Description: Sapacitabine (CS682) is an orally available nucleoside analog precursor compound with potential anti-tumor activity for the study of acute myeloid leukemia. Target: Nucleoside Antimetabolite/Analog. Smiles: CCCCCCCCCC CCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1. References: Serova M,...
| Schlagworte: | CYC682, CS682 |
| Anwendung: | Antineoplastic, Antimetabolite |
| CAS | 151823-14-2 |
| MW: | 490.64 D |
37,00 €
